(Q33853655)

29 July 2017

title

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection (English)

1 reference

29 July 2017

1 reference

Vlahov D

1 reference

29 July 2017

Nelson KE

1 reference

29 July 2017

Thomas DL

1 reference

29 July 2017

Villano SA

1 reference

29 July 2017

Cohn S

series ordinal

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

908-914

1 reference

Epidemiology of hepatitis C

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Hepatitis C: the clinical spectrum of disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Early events in hepatitis C virus infection of chimpanzees.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Evaluation of Two Methods for Quantitation of Hepatitis C Virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Can HCV infection be cleared?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Therapy of hepatitis C: overview

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290311

7 January 2021

Identifiers

DOI

10.1002/HEP.510290311

1 reference

29 July 2017

1 reference